Edition:
United Kingdom

Paratek Pharmaceuticals Inc (PRTK.O)

PRTK.O on Consolidated Issue listed on NASDAQ Global Market

3.32USD
19 Jul 2019
Change (% chg)

$0.13 (+4.08%)
Prev Close
$3.19
Open
$3.19
Day's High
$3.33
Day's Low
$3.15
Volume
319,796
Avg. Vol
297,054
52-wk High
$12.30
52-wk Low
$3.13

About

Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Its product candidates are the antibacterials omadacycline and sarecycline. Omadacycline is an antibiotic being developed for use as an... (more)

Overall

Beta: 1.87
Market Cap(Mil.): $107.62
Shares Outstanding(Mil.): 32.42
Dividend: --
Yield (%): --

Financials

  PRTK.O Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -3.76 -- --
ROI: -57.06 7.77 12.69
ROE: -189.62 8.27 17.17

Earnings vs. Estimates